Sandra Heskamp

29PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersAcceleratorsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 17, 2026
Proof-of-Concept of CAIX-Targeted α-Particle Delivery in a Patient-Derived Hypoxic Head and Neck Squamous Cell Carcinoma Model.

|Jul 15, 2026
Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac.

|May 11, 2026
Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8+ T-cell infiltration.

|Mar 25, 2026
In Vivo Analysis of Neuroblastoma Targeting Potential of aGD2-SIRPα Fusion Antibodies for Local CD47 Blockade.

Fabian Schuurmans, Matthia G M Boros, Renske J E van den Bijgaart

|May 09, 2025
Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity.

Eva Peeters, Evelien A J van Genugten, Sandra Heskamp

|Apr 25, 2025
Efficacy of combined targeted radionuclide therapy and immune checkpoint Inhibition in animal tumour models: a systematic review and meta-analysis of the literature.

Simone C Kleinendorst, Carlijn R Hooijmans, Stijn Muselaers

Pageof 5

Frequent Collaborators

5 joint publications

Johan Bussink

4 joint publications

Erik H J G Aarntzen

3 joint publications

Gosse J Adema

3 joint publications

Martijn Verdoes